Results 21 to 30 of about 46,412 (225)

Synchronous mixed medullary‐papillary carcinoma and papillary multifocal carcinoma of the thyroid with cervical lymph node metastases

Clinical Case Reports, 2023
Key Clinical Message The occurrence of simultaneous multifocal papillary thyroid carcinoma and mixed medullary‐papillary carcinoma, as far as we know, has not been previously described.
Raquel Lalanda, David Aparício, João Boavida, Dolores Lopes Presa, Lucas Batista, Luís Miranda   +5 more
doaj   +1 more source

A case report of diagnosis of liver metastasis of medullary thyroid carcinoma by multimodal ultrasound

Radiology Case Reports, 2023
Medullary thyroid carcinoma is a rare malignant neuroendocrine tumor. Distant metastasis is difficult to detect early. It is most common in lung, liver, bone and brain.
Jie Xue, MD, Xinying Li, Nina Qu, MD, Zhihui Wu, Guoyun Wang, Zhuonan Chenhuang, Xiaoli Cao, MD   +6 more
doaj   +1 more source

Detection rate of FNA cytology in medullary thyroid carcinoma. a meta-analysis [PDF]

, 2015
Background: The early detection of medullary thyroid carcinoma (MTC) can improve patient prognosis, because histological stage and patient age at diagnosis are highly relevant prognostic factors. As a consequence, delay in the diagnosis and/or incomplete
Anna, Crescenzi, Giorgio, Treglia, Leo, Guidobaldi, Luca, Giovanella, Massimo, Bongiovanni, Nigri, Giuseppe, Pierpaolo, Trimboli, Ramin, Sadeghi, Romanelli, Francesco, Valabrega, Stefano, William C., Faquin   +10 more
core   +1 more source

Tumour-to-tumour metastasis: Rectal adenocarcinoma metastasis to medullary carcinoma of thyroid—Case report and review of the literature

Human Pathology Reports, 2022
Tumour-to-tumour metastasis is a rare incidence. Metastasis from colorectal cancer to primary thyroid neoplasm is extremely rare. We report a case of metastatic rectal adenocarcinoma to a medullary thyroid carcinoma.
Mahmoud Elsayed, Andrew McCarthy, Marium Khan   +2 more
doaj   +1 more source

Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma

The International Journal of Biological Markers, 2018
Aim: Due to the limits of calcitonin, other markers are warranted to better manage medullary thyroid carcinoma patients, and procalcitonin has been reported as promising.
Pierpaolo Trimboli, Rosa Lauretta, Agnese Barnabei, Stefano Valabrega, Francesco Romanelli, Luca Giovanella, Marialuisa Appetecchia   +6 more
doaj   +1 more source

Breast metastasis from medullary thyroid carcinoma: a report of a case

Surgical Case Reports, 2021
Background Metastasis to the breast is rare. We herein report a patient with metastatic medullary thyroid carcinoma to the breast for whom measuring the calcitonin level was an important clue to the correct diagnosis.
Yoko Omi, Hidenori Kamio, Yusaku Yoshida, Kenta Masui, Tomoko Yamamoto, Yoji Nagashima, Takahiro Okamoto   +6 more
doaj   +1 more source

External radiotherapy of thyroid cancer [PDF]

, 2001
Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Dühmke, Eckhart, Pollinger, B.
core   +1 more source

Medullary carcinoma of the thyroid - an unusual case of hyalinizing trabecular adenoma - like variant (encapsulated) [PDF]

, 2012
Medullary thyroid carcinoma is a neoplasm occurring in sporadic and familial patterns. A rare variant of medullary thyroid carcinoma shows microscopic features similar to hyalinizing trabecular adenoma of thyroid.
Madhusmita Jena, Vidya Bhat
core   +2 more sources

Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer [PDF]

, 2015
Anaplastic thyroid cancer (ATC) is often incurable so new therapeutic approaches are needed. Tyrosine kinases inhibitors (such as imanitib, sunitinib or sorafenib) are under evaluation for the treatment of ATC.
Bond JA, Cohen EE, Dowlati A, Goulart B, Grande E, Hayashi N, Ibrahim N, Klopper JP, Mahlknecht U, Ohta K, Ruggeri RM, Sherman SI   +11 more
core   +1 more source

Sporadic medullary thyroid carcinoma: clinical data from a university hospital

Clinics, 2009
INTRODUCTION: Medullary thyroid carcinoma may occur in a sporadic (s-medullary thyroid carcinoma, 75%) or in a multiple endocrine neoplasia type 2 form (MEN2, 25%).
Joya Emilie M. Correia-Deur, Rodrigo A. Toledo, Alice T. Imazawa, Delmar M. Lourenço Jr., Marilza C. L. Ezabella, Marcos R. Tavares, Sergio P. A. Toledo   +6 more
doaj   +1 more source